$40.63
▼ $-2.18
(-5.09%)
Vol 1.7M
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$1.7B
ROE
-246.2%
D/E
0.00
Beta
2.65
52W
$2–$31
Wall Street Consensus
11 analysts · Apr 20262
Strong Buy
7
Buy
2
Hold
0
Sell
0
Strong Sell
81.8%
Buy Rating
Price Chart
Similar Stocks
TVTX
Travere Therapeutics Inc
$3.4B
ORKA
Oruka Therapeutics Inc
$1.5B
VCYT
Veracyte Inc
P/E 110.3
$3.3B
BEAM
Beam Therapeutics Inc
$2.8B
IRON
Disc Medicine Inc
$3.0B
IMNM
Immunome Inc
$2.4B
SRPT
Sarepta Therapeutics Inc
$2.3B
BCRX
BioCryst Pharmaceuticals Inc
$1.6B
GRAL
Grail Inc
$3.3B
RLAY
Relay Therapeutics Inc
$1.5B
Earnings
Beat rate: 60.0%
Next Report
May 12, 2026
EPS Estimate: $-0.95
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.95 | — | — |
| Dec 2025 | $-1.06 | $-1.04 | +$0.02 |
| Sep 2025 | $-1.04 | $-1.16 | $-0.12 |
| Jun 2025 | $-1.08 | $-1.03 | +$0.05 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -155.4% | -155.3% | -155.3% | -155.3% | -155.4% | -246.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 3.48 | 3.48 | 3.48 | 3.48 | 3.48 | 1.78 |
Key Ratios
ROA (TTM)
-78.4%
P/B
3.5
EPS (TTM)
$-4.12
CF/Share
$-4.89
52W High
$31.18
52W Low
$1.92
$1.92
52-Week Range
$31.18
How does KOD compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
KOD valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
3.5
▲
42%
above
peers
(2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
KOD profitability vs Biotechnology peers
ROE
-246.2%
▼
266%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-78.4%
▼
68%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
KOD financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
1.8
▼
60%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
2.7
▲
174%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
KOD fundamentals radar
KOD
Peer median
Industry
KOD profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio